Answers are grounded in this paper and cite their sources.
Introduction: Methotrexate (MTX) is an antimetabolite used in the treatment of a variety of cancers and autoimmune disorders with significantly higher hepatotoxic potential ranging from fibrosis to cirrhosis in Western versus Asian populations with no known treatment. Focus on phytotherapy has emerged in this regard. Aims and Objectives: The aim of this work was to test the possible protective effect of *Beta vulgaris* and *Moringa oleifera* leaves against MTX induced hepatotoxicity in rats. Place and Duration of Study: The study was conducted in experimental research laboratory, PGMI, Lahore and was completed in 1 year. Material and Methods: 45 rats were divided into 5 groups of 9 animals each. Group 1 served as healthy controls and Group 2 as diseased control. All extracts were administered in single oral doses daily for 24 days. Groups 3 and 4 were administered 200mg /kg of ethanolic extract of Beta vulgaris (EEBV) and 800 mg/kg ethanolic extract of Moringa oleifera (EEMO) respectively, while Group 5 was given their combined extracts (100mg/kg EEBV+400mg/kg EEMO). On 21st day hepatotoxicity was produced in groups 2-5 by giving single intraperitoneal injection of 20mg/kg MTX. Blood samples were drawn through cardiac puncture at baseline, days 21 and 24 and LFTs were determined. Qualitative data was analyzed using chi-square and p values <0.05 were labeled significant. Results: Ethanolic extracts of Beta vulgaris and Moringa oleifera individually and in combination exhibited significant hepatoprotective effect when administered prior to methotrexate in rats, by maintaining normal murine LFTs (ALP.AST,ALT) with P value <0.05. Conclusion: EEBV and EEMO leaves and their combined extracts possess significant hepatoprotective activity.
No takes yet. Share an insight, caveat, or question.
Shumaila Kanwal (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: